1. The efficacy and safety of keverprazan, a novel potassium‐competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double‐blind multicentre study. Issue 12 (3rd May 2022) Authors: Chen, Songfeng; Liu, Deliang; Chen, Honghui; Liao, Aijun; Li, Fangfang; Liu, Chengxia; Li, Xing; Li, Shengbao; Zhang, Yan; Wang, Yang; Xia, Min; Guo, Qinghong; Miao, Xinpu; Wen, Zhili; Xu, Min; Yin, Hekun; Chen, Huixin; Chen, Minhu; Xiao, Yinglian Journal: Alimentary pharmacology & therapeutics Issue: Volume 55:Issue 12(2022) Page Start: 1524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗